Climb Bio, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Jarvis is thinking

Climb Bio, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Income Statement

	2025-12-31	2024-12-31
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$67.88M	-$82.02M
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$59.85M	-$73.90M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-0.88	$-1.53
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-0.88	$-1.53

Balance Sheet

	2025-12-31	2024-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$35.69M	$87.23M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$167.74M	$217.19M
Everything the company owes — debt, unpaid bills, and other obligations.	$7.27M	$5.31M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$160.47M	$211.88M

Cash Flow Statement

	2025-12-31	2024-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$54.36M	-$15.56M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$186000	$4.64M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$54.54M	-$20.21M